These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure. Akhtar MM; Lorenzini M; Pavlou M; Ochoa JP; O'Mahony C; Restrepo-Cordoba MA; Segura-Rodriguez D; Bermúdez-Jiménez F; Molina P; Cuenca S; Ader F; Larrañaga-Moreira JM; Sabater-Molina M; Garcia-Alvarez MI; Arantzamendi LG; Truszkowska G; Ortiz-Genga M; Ruiz IS; Nielsen SK; Rasmussen TB; Robles Mezcua A; Alvarez-Rubio J; Eiskjaer H; Gautel M; Garcia-Pinilla JM; Ripoll-Vera T; Mogensen J; Limeres Freire J; Rodríguez-Palomares JF; Peña-Peña ML; Rangel-Sousa D; Palomino-Doza J; Arana Achaga X; Bilinska Z; Zamarreño Golvano E; Climent V; Peñalver MN; Barriales-Villa R; Charron P; Yotti R; Zorio E; Jiménez-Jáimez J; Garcia-Pavia P; Elliott PM; JAMA Cardiol; 2021 Aug; 6(8):891-901. PubMed ID: 33978673 [TBL] [Abstract][Full Text] [Related]
30. Association of the Obesity Paradox With Objective Physical Activity in Patients at High Risk of Sudden Cardiac Death. Li X; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Xue X; Zhang S; Zhao S J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32942298 [TBL] [Abstract][Full Text] [Related]
31. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. Rowin EJ; Maron BJ; Carrick RT; Patel PP; Koethe B; Wells S; Maron MS J Am Coll Cardiol; 2020 Jun; 75(24):3033-3043. PubMed ID: 32553256 [TBL] [Abstract][Full Text] [Related]
32. Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. Coppini R; Ho CY; Ashley E; Day S; Ferrantini C; Girolami F; Tomberli B; Bardi S; Torricelli F; Cecchi F; Mugelli A; Poggesi C; Tardiff J; Olivotto I J Am Coll Cardiol; 2014 Dec; 64(24):2589-2600. PubMed ID: 25524337 [TBL] [Abstract][Full Text] [Related]
33. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962 [TBL] [Abstract][Full Text] [Related]
34. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy. Sridharan A; Maron MS; Carrick RT; Madias CA; Huang D; Cooper C; Drummond J; Maron BJ; Rowin EJ J Cardiovasc Electrophysiol; 2022 Jan; 33(1):20-29. PubMed ID: 34845799 [TBL] [Abstract][Full Text] [Related]
35. Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy. Pasqualucci D; Fornaro A; Castelli G; Rossi A; Arretini A; Chiriatti C; Targetti M; Girolami F; Corda M; Orrù P; Matta G; Stefàno P; Cecchi F; Porcu M; Olivotto I Circ Heart Fail; 2015 Nov; 8(6):1014-21. PubMed ID: 26446673 [TBL] [Abstract][Full Text] [Related]
36. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy. Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106 [TBL] [Abstract][Full Text] [Related]
37. Friedreich's ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study. Norrish G; Rance T; Montanes E; Field E; Brown E; Bhole V; Stuart G; Uzun O; McLeod KA; Ilina M; Adwani S; Daubeney P; Delle Donne G; Linter K; Jones CB; Bharucha T; Cervi E; Kaski JP Arch Dis Child; 2022 May; 107(5):450-455. PubMed ID: 34610949 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Nistri S; Olivotto I; Betocchi S; Losi MA; Valsecchi G; Pinamonti B; Conte MR; Casazza F; Galderisi M; Maron BJ; Cecchi F Am J Cardiol; 2006 Oct; 98(7):960-5. PubMed ID: 16996883 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator. Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675 [TBL] [Abstract][Full Text] [Related]
40. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function. Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]